Amneal Expands Injectables Portfolio With Four Approvals

As Atroprine Receives CGT Status by the FDA

 
• By Akriti Seth
  
four launches
Amneal adds four approvals to its expanding generic injectables portfolio • Source: Alamy
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Generics

More from Products